top of page
Very premature babies with PH who respond to inhaled nitric oxide have better survival
A study looked at 262 very premature babies diagnosed with pulmonary hypertension who were given inhaled nitric oxide. For babies whose...
Robyn Kalda
Sep 1, 20251 min read
New PAH-associated genes identified
In the body, variations in several genes were associated with a more than 20-fold increased risk of pulmonary arterial hypertension...
Robyn Kalda
Aug 29, 20251 min read


PHA Canada Partners with Vision Quest Communications to Launch Indigenous Advisory Council Initiative
The Pulmonary Hypertension Association of Canada (PHA Canada) is proud to announce a new partnership with Vision Quest Communications...

PHA Canada
Aug 21, 20252 min read
Uric acid might cause PAH
Other studies have shown a relationship between high levels of uric acid and pulmonary arterial hypertension (PAH). This study looked at...
Robyn Kalda
Aug 18, 20251 min read


Representation can be subtle, but inclusion can make a big difference.
Taking in stories over this Disability Pride Month has left me both humbled and hopeful. A few weeks ago, I started doing some work for a...
Kaitlyn Salonga, Patient
Aug 7, 20251 min read


Heat, Haze & Helpful Hints
Yesterday, Colin Van De Wetering, a Registered Respiratory Therapist and Certified Respiratory Educator, joined our Monthly Meet-Up to...

PHA Canada
Aug 6, 20252 min read
Non-oral therapies burden PAH patients
This study looked at the challenges and impacts of non-oral treatments for pulmonary arterial hypertension (PAH), beyond those caused by...
Robyn Kalda
Aug 4, 20251 min read


How much is too much? New guidelines released for determining excessive drug pricing
For years, PHA Canada has been working to ensure that the drug approval process in Canada meets the needs of our pulmonary hypertension...

PHA Canada
Jul 25, 20252 min read
Global report warns of dangerous gaps in respiratory health awareness and research
For Immediate Release Global report warns of dangerous gaps in respiratory health awareness and research Authors urge for action plan...

PHA Canada
Jul 21, 20253 min read
Early dual treatment helps late-diagnosed PAH patients catch up
Early use of dual therapy helps newly-diagnosed pulmonary arterial hypertension patients do as well as patients six months past...
Robyn Kalda
Jul 21, 20251 min read
Good news: treatments have significantly increased five-year survival for CTEPH
Since the 1980s, treatment options for patients with chronic thromboembolic pulmonary hypertension (CTEPH) have increased. This study...
Robyn Kalda
Jul 18, 20251 min read


10 Calls to Action for improving care for adult patients living with pulmonary hypertension
The Pulmonary Hypertension Global Patient Survey (PHGPS), the largest survey to date to explore the perspectives of patients with PH at...

PHA Canada
Jul 17, 20252 min read


Items that make living with pulmonary hypertension easier
Here are a few things that the Canadian PHriends Facebook group members found make their lives easier. Around the house Air conditioning...

PHA Canada
Jul 17, 20251 min read
Hymecromone clinical trial is cautiously positive
A very small (16 patients) phase 2a clinical trial for pulmonary hypertension associated with interstitial lung disease (PH-ILD) looked...
Robyn Kalda
Jul 7, 20251 min read
Meth-associated PAH care gaps: closing the divide
We know methamphetamine use is associated with pulmonary arterial hypertension (PAH), but this population's care needs haven't been...
Robyn Kalda
Jun 23, 20251 min read


Canada Disability Benefit applications open this week
Applications for the Canada Disability Benefit (CDB) open this week. If you're eligible for the Disability Tax Credit and you (and your...
PHA Canada
Jun 17, 20251 min read


Honouring Andrew Barfoot: A Day of Community, Kindness, and Legacy
On a beautiful June day filled with sunshine and warmth, our community gathered for a special fundraiser in honour of Andrew Barfoot....
Sherry Foster
Jun 10, 20252 min read
IV selexipag can be used as a bridging therapy
Pulmonary arterial hypertension patients who take selexipag normally take it orally (as a pill). Sometimes, though, this is temporarily...
PHA Canada
Jun 9, 20251 min read


Quick Facts: What is Yutrepia?
What it is Yutrepia is a new drug: an inhaled form of treprostinil, a prostacyclin analogue. It was just approved by the Food and Drug...
PHA Canada
Jun 3, 20251 min read


From Diagnosis to Advocacy: Heather’s PAH Journey
I was diagnosed with pulmonary arterial hypertension (PAH) in June 2024. In hindsight, knowing the symptoms as I do now, I might have had...
PHA Canada
May 29, 20252 min read
bottom of page
